Thioridazine |
GBM8401, U87MG glioma cells |
↑ |
↑ |
AMPK↑ |
Apoptotic death; Tumor growth in vivo↓ |
53 |
Trifluoperazine |
MDA-MB-231 breast cancer cells |
↑ |
n.a. |
n.a. |
Migration↓; Invasiveness↓ |
54 |
Trifluoperazine |
Ca922, SCC2095, primary oral cancer cells |
↑ |
n.a. |
Akt/mTORC1↓ |
Apoptotic death; Tumor growth in vivo↓ |
58 |
Trifluoperazine |
HeLa cells |
↑ |
↑ |
n.a. |
Bacterial clearance |
61 |
Trifluoperazine |
H4 glioma cells |
↑ |
↑ |
Ca2+↓, calpain↓, ATG5 cleavage↓ |
Clearance of mutant; poliglutamine |
13,59
|
Fluspirilene |
H4 glioma cells |
↑ |
↑ |
Ca2+↓, calpain↓, ATG5 cleavage↓ |
Clearance of mutant; poliglutamine |
13,59
|
Pimozide |
H4 glioma cells |
↑ |
↑ |
Ca2+↓, calpain↓, ATG5 cleavage↓ |
Clearance of mutant; poliglutamine |
13,59
|
Penfluridol |
Panc-1, AsPC-1, BxPC-3; pancreatic cancer cells |
↑ |
↑ |
n.a. |
Apoptotic death; Tumor growth in vivo↓ |
55 |
Chlorpromazine |
U87MG glioma cells |
↑ |
↑ |
Akt/mTORC1↓ |
Apoptotic death; Tumor growth in vivo↓ |
56 |
Olanzapine |
LN229, T98 glioma cells |
↑ |
↑ |
n.a. |
Apoptotic death; Tumor growth in vivo↓ |
57 |
Clozapine |
A549, H1299 lung cancer cells |
↑ |
↑ |
n.a. |
Cell cycle arrest; Cell death |
60 |
Clozapine |
Mouse skeletal muscle |
↓ |
n.a. |
PKCβ↑, LC3 conversion↓ |
Lipid droplet clearance↓; Weight gain |
63 |
Fluphenazine |
Mouse liver |
↑ |
n.a. |
n.a. |
ATZ clearance; Liver fibrosis↓ |
62 |